high-cost treatments that target a patient's genetic source or cell to cure or significantly alter the course of a disease. Pfizer on Wednesday said its experimental gene therapy for a rare ...

A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases. SpringWorks is the brainchild of Lara Sullivan, a former Pfizer R&D strategy executive who gained Pfizer's ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

A total of three cases of Creutzfeldt-Jakob disease, a rare and incurable brain condition, have been detected in Hood River ...

Paid and presented by Pfizer. To everyone except his family ... are helping the healthcare community recognise and diagnose rare diseases and support patients more confidently.

and rare diseases. It also develops and manufactures vaccines. Pfizer collaborated with German biotech company BioNTech SE (BNTX) to develop one of the world's most widely used mRNA-based vaccines ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for autoimmune diseases. The collaboration between Pfizer and Pioneering Medicines, ...

On December 1, Pfizer became the first big pharma to commit to take to market a late-stage biologic drug produced in plant cells. It acquired rights to taligurase alfa, a form of the enzyme ...

Shares of Pfizer Inc (NYSE:PFE) dipped 1.5% as the pharmaceutical giant announced the discontinuation of its drug candidate danuglipron, which was under investigation for chronic weight management.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to ...